Drug-induced liver injury in older people
- 1 September 2020
- journal article
- review article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 5 (9) , 862-874
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (PI 18_01804, PT17/0017/0020)
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Federación Española de Enfermedades Raras
- Instituto de Salud Carlos III
This publication has 79 references indexed in Scilit:
- HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate HepatotoxicityPLOS ONE, 2013
- Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and ManagementJournal of Clinical and Experimental Hepatology, 2013
- Limited contribution of common genetic variants to risk for liver injury due to a variety of drugsPharmacogenetics and Genomics, 2012
- Liver Regeneration and Aging: A Current PerspectiveCurrent Gerontology and Geriatrics Research, 2011
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- Outcome of acute liver failure in the elderly1Liver Transplantation, 2009
- Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver FailureGastroenterology, 2009
- Phenotypic characterization of idiosyncratic drug‐induced liver injuryHepatology, 2009
- Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United StatesGastroenterology, 2008
- Aminoglycoside-associated nephrotoxicity in extrahepatic obstructive jaundiceJournal of Hepatology, 1995